CRL - Latest News

Charles River Laboratories International, Inc. (CRL), operates in Healthcare / Medical - Diagnostics & Research, trades on NYSE.

Market capitalization stands near $10.39B. Beta to the broader market is 1.45.

The article list below shows the most recent CRL headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent CRL Headlines

Achieve Life Sciences: CRL Is Fixable, So I Remain Bullish

seekingalpha.com - Jun 23, 2026

Achieve Life Sciences remains a cytisinicline story, with very positive smoking-cessation data. This also gives cytisinicline some added optionality

Bio-Rad vs. Charles River Labs: Which Medical Research Stock Is a Better Buy in 2026?

fool.com - Jun 22, 2026

Bio-Rad Laboratories offers high profitability and a liquid balance sheet with a current ratio above 5x. Charles River Laboratories International mai

Charles River Joins Lilly TuneLab to Optimize AI/ML Platform through Nonclinical Testing Expertise

businesswire.com - Jun 18, 2026

WILMINGTON, Mass. --(BUSINESS WIRE)---- $CRL #LIFEatCRL--Charles River Laboratories International, Inc.

The Healthcare M&A Wave

forbes.com - Jun 17, 2026

In this week's edition of InnovationRx, we look at biotech M&A, the rise of India's Anthem Biosciences, and more. To get it in your inbox, subscribe

Disc Medicine: The CRL Has Created A Cleaner Bull Case

seekingalpha.com - Jun 17, 2026

Disc Medicine (IRON) offers a differentiated hematology platform with late-stage assets, robust cash reserves, and a clear regulatory path for bitoper

How News Affects CRL Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track CRL's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked CRL news questions

What is the latest CRL news headline?

The most recent CRL headline (Jun 23, 2026) is "Achieve Life Sciences: CRL Is Fixable, So I Remain Bullish". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.

How fresh is the CRL news on this page?

News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.

What CRL news moves options pricing?

Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.

How can I track unusual CRL options activity related to news?

Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.